FGP
CME icon

Freestone Grove Partners’s CME Group CME Stock Holding History

Freestone Grove Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.6M Sell
56,153
-63,870
-53% -$19M 0.12% 232
2025
Q4 		$32.8M Buy
120,023
+72,593
+153% +$19.7M 0.24% 134
2025
Q3 		$12.8M Buy
+47,430
New +$12.9M 0.1% 265
2025
Q1 		– Sell
-13,154
Closed -$3.05M – 618
2024
Q4 		$3.05M Buy
+13,154
New +$3.02M 0.04% 250

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Freestone Grove Partners's CME Position: Q1 2026 in Review

Freestone Grove Partners reduced its CME Group (CME) stake by 53% in Q1 2026, selling an estimated $19M and leaving 56,153 shares worth $16.6M. The position accounts for 0.12% of the portfolio, ranked #232.

Freestone Grove Partners first reported a position in CME in Q4 2024 and has held it in 4 quarters since. The position peaked at $32.8M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Freestone Grove Partners held 56,153 shares of CME Group worth $16.6M as of Q1 2026.
  • Freestone Grove Partners sold 63,870 CME Group shares in Q1 2026, an estimated $19M.
  • CME Group made up 0.12% of Freestone Grove Partners's portfolio in Q1 2026, its #232 holding.
  • Freestone Grove Partners first reported a position in CME Group in Q4 2024 and has held it in 4 quarters since.
  • Freestone Grove Partners's CME Group position peaked at $32.8M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.